Skip to content

Tanke Biosciences Corp

TNBI · OTCM

CIK 1452011fmd_09MTDAN5MSJY4XX4Z6W5XGQD93Manufacturing · Grain Mill ProductsTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2013, 15 periods

Income Statement · Annual · Millions · USD
Line itemFY2009FY2010FY2011FY2012
Total revenues–202429
Cost of revenue–131519
Gross profit–7910
Research and development––00
Operating income–425
Interest expense–011
Interest and investment income–000
Income before taxes–4(2)1
Income tax expense–111
Net income from continuing operations–4(3)(0)
Net income33(3)(0)
Tanke Biosciences Corp (TNBI) financial statements · FinancialMD